{"name":"Seng Gee Lim","slug":"seng-gee-lim","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Nucleos(t)ide analogue therapy","genericName":"Nucleos(t)ide analogue therapy","slug":"nucleos-t-ide-analogue-therapy","indication":"Chronic hepatitis B","status":"marketed"}]}],"pipeline":[{"name":"Nucleos(t)ide analogue therapy","genericName":"Nucleos(t)ide analogue therapy","slug":"nucleos-t-ide-analogue-therapy","phase":"marketed","mechanism":"Nucleos(t)ide analogues inhibit viral reverse transcriptase and/or polymerase, preventing viral DNA synthesis and replication.","indications":["Chronic hepatitis B","HIV infection"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9qeksxMHI1MUJKdm9udFJXSzNCUkpPV29GckM0cWxOVVVWWmNUdVpuRktPT0pPNEVGbmlUNXRPdzVsOHlvV2EzOWhXejJjZU8zUWpmR0dqZWMwSkREREdJ?oc=5","date":"2022-11-08","type":"pipeline","source":"NEJM","summary":"Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection - NEJM","headline":"Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxPVUlQVXFncUI2WHh1aVpoVlRSZW1hcm9NRGtmY3puQ0lBd3dMZkxla3J1ZjhpdTVOU2FRV0U0OWNJNG5jTkw5RnFxdTVOQXd5R01IQmFtbjRaaFF3V0k4R0M5cDRVSzZiYVB2Zi10c09iWVNPeFhKNGdjWTNEX0hrSFpjV2Y2SlktMHJLb3B5QkRRWVo3OXlmRjVnajRjM0dwR2RYREg3Vi05ZkZ5QUVzMXlYSENIQzZkSnVKOWR4VjF6TzhOWU1fa0NYZFZ5UkU0cEMzYVNwOUJiWlhId3Zz?oc=5","date":"2020-11-13","type":"pipeline","source":"BioSpectrum Asia","summary":"Enhancing Survival of HCC Patients in The New Era - A Multi-disciplinary Team Approach - BioSpectrum Asia","headline":"Enhancing Survival of HCC Patients in The New Era - A Multi-disciplinary Team Approach","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}